Izvorni znanstveni članak
Analysis of International Mergers and Acquisitions in the Pharmaceutical Industry
Božo Matić
Vlatka Bilas
Vedran Bači
Sažetak
There are numerous researches which analyze mergers and acquisitions, but most of them do not
focus on a certain industry, but their sample considers companies from different industries. This paper
focuses on mergers and acquisitions in the pharmaceutical industry. It is assumed that pharmaceutical
companies with no experience in mergers and acquisitions achieve better results in relatively small and
domestic mergers and acquisitions while pharmaceutical companies with greater experience in mergers
and acquisitions are successful even in bigger and international mergers and acquisitions. Bigger mergers
and acquisitions and international mergers and acquisitions are more risky for the companies so lack of
experience in mergers and acquisitions additionally increases risks during the process of mergers and
acquisitions. On average, such increase of the risk results in lower returns for stock owners of pharmaceutical
companies.
Ključne riječi
mergers and acquisitions; successfulness of the international mergers and acquisitions; pharmaceutical industry
Hrčak ID:
70555
URI
Datum izdavanja:
10.7.2011.
Posjeta: 3.940 *